CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Akers Biosciences Inc 's Quick Ratio

AKER's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




AKER Quick Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Current Liabilities Change 4.99 % -22.48 % -40.34 % -12.65 % 50.52 %
Y / Y Cash & cash equivalent Change 56.57 % 77.49 % -47.98 % -48.28 % -49.04 %
Quick Ratio MRQ 3.41 6.33 2.34 2.64 2.29
Overall Ranking # # # # #
Seq. Current Liabilities Change 42.5 % 11.42 % -15.13 % -22.09 % 5.22 %
Seq. Cash & cash equivalent Change -23.13 % 201.75 % -24.84 % -10.19 % -12.86 %



Quick Ratio first quarter 2020 Comment
Due to increase in Current Liabilities in the first quarter 2020, Quick Ratio fell to 3.41 below Akers Biosciences Inc average.

Within Biotechnology & Drugs industry 103 other companies have achieved higher Quick Ratio than Akers Biosciences Inc in first quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are AKER Segments?
See Quick Ratio AKER on the trailing twelve month basis
Quick Ratio first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 104
Healthcare Sector # 342
Overall Market # 708


Quick Ratio Statistics
High Average Low
13.57 4.2 0.07
(Mar 31 2014)   (Dec 31 2016)




Financial Statements
Akers Biosciences Inc 's Current Liabilities $ 2 Millions Visit AKER's Balance sheet
Akers Biosciences Inc 's Cash & cash equivalent $ 7 Millions Visit AKER's Balance sheet
Source of AKER's Sales Visit AKER's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2020, within Biotechnology & Drugs Industry Quick RatioMar 31 2020 MRQ Cash & cash equivalentMar 31 2020 MRQ Current Liabilities
Immunomedics Inc   9.12 $ 540.620  Millions$ 59.268  Millions
Catalyst Biosciences Inc   8.82 $ 104.528  Millions$ 11.853  Millions
Regenxbio Inc   8.78 $ 279.257  Millions$ 31.789  Millions
Heska Corp  8.73 $ 191.245  Millions$ 21.906  Millions
Seneca Biopharma Inc   8.46 $ 10.030  Millions$ 1.186  Millions
Diffusion Pharmaceuticals Inc   8.41 $ 10.828  Millions$ 1.287  Millions
Urogen Pharma Ltd   8.38 $ 119.091  Millions$ 14.207  Millions
Neogen Corp  8.38 $ 327.923  Millions$ 39.135  Millions
Immunovant Inc   8.29 $ 100.571  Millions$ 12.128  Millions
Livongo Health Inc   8.24 $ 368.228  Millions$ 44.695  Millions
Proteostasis Therapeutics Inc   8.13 $ 57.104  Millions$ 7.025  Millions
Myokardia Inc   7.67 $ 350.013  Millions$ 45.660  Millions
Salarius Pharmaceuticals inc   7.61 $ 9.647  Millions$ 1.267  Millions
Tracon Pharmaceuticals Inc   7.59 $ 14.134  Millions$ 1.861  Millions
Arcus Biosciences Inc   7.52 $ 157.866  Millions$ 21.004  Millions
Unity Biotechnology Inc   7.50 $ 109.238  Millions$ 14.569  Millions
Opiant Pharmaceuticals Inc   7.44 $ 32.198  Millions$ 4.326  Millions
Adma Biologics Inc   7.35 $ 101.236  Millions$ 13.765  Millions
Protara Therapeutics Inc   7.30 $ 36.069  Millions$ 4.943  Millions
Casi Pharmaceuticals Inc   7.23 $ 54.495  Millions$ 7.541  Millions
Intellia Therapeutics Inc   7.09 $ 250.259  Millions$ 35.304  Millions
Cytrx Corp  7.04 $ 15.297  Millions$ 2.173  Millions
Atara Biotherapeutics Inc   6.81 $ 214.631  Millions$ 31.520  Millions
Eyenovia Inc   6.81 $ 13.774  Millions$ 2.024  Millions
Surface Oncology Inc   6.73 $ 90.084  Millions$ 13.379  Millions
Zymeworks Inc   6.69 $ 487.664  Millions$ 72.905  Millions
Adaptimmune Therapeutics Plc  6.59 $ 196.429  Millions$ 29.816  Millions
Vir Biotechnology Inc   6.47 $ 364.712  Millions$ 56.396  Millions
Applied Genetic Technologies Corp  6.24 $ 84.517  Millions$ 13.548  Millions
Xenetic Biosciences Inc   6.21 $ 9.367  Millions$ 1.507  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GHM's Profile

Stock Price

GHM's Financials

Business Description

Fundamentals

Charts & Quotes

GHM's News

Suppliers

GHM's Competitors

Customers & Markets

Economic Indicators

GHM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071